The company also reaffirmed its guidance for the fourth quarter, and continues to expect revenues of $46.5 million to $48.0 million and EPS of $.09 to $.11.
In Science this week: single-cell tools named Breakthrough of the Year winner, differences in gut microbiome composition and function in people with bowel disease, and more.
Hmong and Karen immigrants to the US quickly lost diversity in their microbiomes and experienced shifts in the microbes present in their guts.
Each stage is associated with an increase in gut microbial diversity and is influenced by breastfeeding, researchers reported this week.
New York City Department of Health and Mental Hygiene researchers discovered almost 700 bacterial species in the city's drinking water, including samples before and after treatment.
Stanford University researchers used a new bioinformatic tool they developed to examine relatedness between bloodstream pathogens and the gut microbiome.
The researchers characterized how gene therapy affects the immune cell repertoires and microbiomes of X-linked severe combined immunodeficiency patients.
Researchers find that fecal microbiome transplants restore gut bacteria in cancer patients who underwent antibiotic treatment for a stem cell transplant.
Researchers profiled the composition and gene content of microbial communities in mouth, gut, and vaginal samples collected from 10 pregnant women.
In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.
A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.
The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.
LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.
In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.